Navigation Links
Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
Date:1/7/2008

NATICK, Mass., Jan. 7 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Cardiac Surgery and Vascular Surgery businesses to the Getinge Group of Sweden for $750 million in cash. The sale follows the definitive agreement announced on November 5, 2007.

The Company expects to record after-tax charges of approximately $240 million in connection with the transaction. These charges will be recorded during the fourth quarter of 2007 and the first quarter of 2008.

"We have now sold three of our five previously identified non-strategic businesses, and we expect to close on the remaining two -- Fluid Management and Venous Access -- this quarter," said Jim Tobin, President and Chief Executive Officer of Boston Scientific. "These divestitures -- along with our ongoing efforts to reduce expenses and simplify our operating model -- should help us achieve our overall goals of restoring profitable growth, increasing shareholder value and strengthening Boston Scientific for the future."

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward- looking statements are ba
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
2. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
3. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
4. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
5. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
6. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
7. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
8. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
11. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... -- Researchers have discovered a new explanation for differences in ... copies of a certain gene, the more serious the handicap. ... is suspected that it is the amount of copies of ... published in the American Journal of Human Genetics , ... Guy Froyen connected to VIB, a life sciences research institute ...
(Date:12/11/2009)... CAMBRIDGE, Mass., Dec. 11 Gwathmey, ... company specializing in cancer, staph aureus, and cardiovascular ... Pre-clinical Services announced today that Rosalie Dunn, Ph.D., ... Dr. Dunn has over 28 years of experience ... Prior to joining Gwathmey, Dr. Dunn managed ...
(Date:12/10/2009)... Endologix, Inc. (Nasdaq: ELGX ), developer of ... that Dan Lemaitre, former President and CEO of ... effective December 11, 2009. Endologix now has ... Franklin D. Brown, Chairman of the Board, said, ... the Endologix Board of Directors. He has ...
(Date:12/10/2009)... provider of advanced flow measurement, control, and level ... company as Global Level Product Manager effective November ... to enhance market penetration of the level measurement ... Instrument from Lafarge Corp, a manufacturer of building ... and Sales. Bayda will report to Brooks Instrument ...
Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Endologix Appoints Dan Lemaitre to its Board of Directors 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3
... the global specialty biopharmaceutical company,announces results for the three months to March 31, 2009. , Financial Highlights, ... ... ... Product sales (excluding ADDERALL XR) $460 million ...
... by Microfluidics and Imaging -- Net Loss Narrowed by $0.07 ... Inc. (Nasdaq: CALP ) today reported its first ... $28.5 million compared to $29.3 million in the first quarter ... of 2008 included $2.9 million of revenue related to product ...
... and VANCOUVER, April 30 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals (NASDAQ: ... first quarter financial results will be released on Thursday ... a conference call and live webcast at 4:30 p.m. ... quarter results and provide an update on the business ...
Other Biology Technology:Shire begins the year with a strong performance 2Shire begins the year with a strong performance 3Shire begins the year with a strong performance 4Shire begins the year with a strong performance 5Shire begins the year with a strong performance 6Shire begins the year with a strong performance 7Shire begins the year with a strong performance 8Shire begins the year with a strong performance 9Shire begins the year with a strong performance 10Shire begins the year with a strong performance 11Shire begins the year with a strong performance 12Shire begins the year with a strong performance 13Shire begins the year with a strong performance 14Shire begins the year with a strong performance 15Shire begins the year with a strong performance 16Shire begins the year with a strong performance 17Shire begins the year with a strong performance 18Shire begins the year with a strong performance 19Shire begins the year with a strong performance 20Shire begins the year with a strong performance 21Shire begins the year with a strong performance 22Shire begins the year with a strong performance 23Shire begins the year with a strong performance 24Shire begins the year with a strong performance 25Shire begins the year with a strong performance 26Shire begins the year with a strong performance 27Shire begins the year with a strong performance 28Shire begins the year with a strong performance 29Shire begins the year with a strong performance 30Shire begins the year with a strong performance 31Shire begins the year with a strong performance 32Shire begins the year with a strong performance 33Caliper Life Sciences Reports First Quarter 2009 Results 2Caliper Life Sciences Reports First Quarter 2009 Results 3Caliper Life Sciences Reports First Quarter 2009 Results 4
(Date:12/11/2009)... How does a cell manage to identify and degrade ... the body against serious diseases? The researchers Sabine C. ... Ernst Jarosch of the Max Delbrck Center for Molecular ... piece in this puzzle. In an enzyme complex that ... proteins, they discovered a scaffold regulating the identification and ...
(Date:12/11/2009)... about the deep ocean,s temperature variability and circulation system ... The deep ocean is affected more by surface warming ... accurate predictions of factors such as sea level rise ... have also been found to result in a more ... a faster transport of large quantities of warm water, ...
(Date:12/11/2009)... moderate amount of weight by eating less and exercising ... Washington University School of Medicine in St. Louis. , ... Dec. 15, 2009, issue of the Journal of ... loss led to improvement in four key measures of ... study participants included decreased thickness of heart muscle, improved ...
Breaking Biology News(10 mins):MDC researchers identify a scaffold regulating protein disposal 2New discoveries could improve climate projections 2Moderate weight loss in obese people improves heart function 2Moderate weight loss in obese people improves heart function 3Mediterranean Diet May Be Best for Type 2 Diabetes 55765 1Mediterranean Diet May Be Best for Type 2 Diabetes 55765 2Mediterranean Diet May Be Best for Type 2 Diabetes 55765 3JFKs Health Problems More Complex Than Thought 55762 1JFKs Health Problems More Complex Than Thought 55762 2JFKs Health Problems More Complex Than Thought 55762 3Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference 55759 1
... Turn up the white noise, says a team of ... the benefits of noise. Their findings could lead to ... an assistant professor of computer science, Joseph Martin, a ... of biology, are working together to explain the biological ...
... mass index, or BMI, long considered the standard for measuring ... be as accurate as originally thought, according to new research. ... Valley State University measured the BMI of more than 400 ... ?and found that in most cases the student's BMI did ...
... but for those with arousal system disturbances in their brains, ... could sense they were really outside their own body watching ... 6 percent said they have had such an out-of-body experience. ... University of Kentucky have studied the link between out-of-body experiences, ...
Other Biology News:Noise echoes in cell communications 2BMI not accurate indicator of body fat 2Out-of-body experiences may be caused by arousal system disturbances in brain 2
Rabbit polyclonal to SpUlp2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SNNERQSLSSGSND, corresponding to amino acids 622-635 of Schizosaccharomyces pombe SpUlp2...
Lipid Phosphate Phosphohydrolase 2...
Request Info...
Chicken polyclonal to Thioredoxin domain containing 9 ( Abpromise for all tested applications). Antigen: Full length protein (Human) Entrez Gene ID: 10190 Swiss Protein ID: O14530...
Biology Products: